Patent details

92904 Product Name: nivolumab

Basic Information

Publication number:
92904
Type:
SPC
SPC Type:
Medical
Basic Patent Number:
EP090136870
Legal Status:
Inactive
Application number:
92904
First applicant's nationality:
Procedural language:
French

Paediatric Extension

SPC Extension Filing Date:
29/06/2023
SPC Extension Agent Name:
Dennemeyer & Associates S.A.
SPC Extension Status:
Granted
SPC Extension Grant Date:
21/10/2024
SPC Extension Rejection Date:

Marketing Authorization

Marketing Authorization Number:
EU/1/15/1014 - nivolumab
Marketing Authorization Type:
Marketing Authorization Date:
24/06/2015
Marketing Authorization Status:
Accepted
Marketing Authorization Country:

Dates

Filing date:
10/12/2015
First Marketing Authorization date:
24/06/2015
Grant date:
10/02/2016
Activation date:
Publication date:
10/02/2016
Lapsed date:
Expiration date:
Renunciation date:
Revocation date:
Annulment date:
Basic SPC Expiration:
24/06/2030
SPC Extension Expiration:
24/12/2030
Rejection date:
Withdrawal date:

Owner

From:
10/12/2015
 
 

Name:
E. R. Squibb & Sons L.L.C.
Address:
Route 206 & Province Line Road, Princeton, NJ 08540, United States (US)

Name:
ONO Pharmaceutical Co. Ltd.
Address:
1-5, Doshomachi 2-chome Chuo-ku, Osaka-shi, Osaka 541-8526, Japan (JP)

Agent

Name:
DENNEMEYER & ASSOCIATES S.A. PATENT DEPARTMENT
From:
10/12/2015
Address:
PO Box 1502, 1015, LUXEMBOURG, Luxembourg (LU)
To:

Inventor

1

Name:
Wang Changyu
Address:
United States (US)

2

Name:
Srinivasan Mohan
Address:
United States (US)

3

Name:
Cardarelli Josephine M.
Address:
United States (US)

4

Name:
Selby Mark. J.
Address:
United States (US)

5

Name:
Huang Haichun
Address:
United States (US)

6

Name:
Korman Alan, J.
Address:
United States (US)

7

Name:
Chen Bing
Address:
United States (US)

Publication

Bulletin

1

Bulletin Heading:
SPCX1
Bulletin edition number:
2023/08
Publication date:
03/07/2023
Description:
Section G : Applications for extensions for pediatric use – I1E publication

2

Bulletin Heading:
SPCX2
Bulletin edition number:
2024/13
Publication date:
05/11/2024
Description:
Section H : Granted extensions for pediatric use of supplementary protection certificates – I2E publication

Annual Fees

Annual Fee Due Date:
31/05/2026
Annual Fee Number:
21
Annual Fee Amount:
410 Euro
Expected Payer:
Last Annual Fee Payment Date:
Last Annual Fee Paid Number:
Payer:
Filing date Document type Number of pages
29/06/2023 Application Form 4
29/06/2023 Marketing authorization 3
29/06/2023 Paediatric investigation plan 1
30/06/2023 Outgoing Correspondence 1
29/06/2023 Summary of the product caracteristics 136
30/06/2023 Publication 1
21/10/2024 Publication 1
21/10/2024 Certificate 1
30/06/2023 FNET_DC_FRONTPAGE 1
22/10/2024 Outgoing Correspondence 1